1
Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin
Condition(s):AIDS; TuberculosisLast Updated:May 16, 2019Terminated
Lopinavir: 481 Clinical Trials, Page 1 of 49
Hide Studies Not Open or Pending
2
Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions
Condition(s):BioequivalenceLast Updated:December 31, 2020Completed
3
Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB
Condition(s):Acquired Immunodeficiency Syndrome; TuberculosisLast Updated:May 11, 2017Completed
4
Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China
Condition(s):HIV-1 InfectionsLast Updated:August 3, 2011Completed
5
Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)
Condition(s):COVID-19Last Updated:May 27, 2020Terminated
6
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
Condition(s):Coronavirus Infections; Post-exposure ProphylaxisLast Updated:April 21, 2020Recruiting
7
An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin
Condition(s):HIV Infection; TuberculosisLast Updated:May 19, 2015Completed
8
Lopinavir/Ritonavir (Kaletra) PK in Children
Condition(s):HIV/AIDS Treatment; HIV InfectionsLast Updated:July 6, 2012Completed
9
Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily
Condition(s):HIVLast Updated:October 6, 2016Completed
10
A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Condition(s):HIVLast Updated:December 21, 2015Completed